Search

Emeis SA

Gesloten

14.56 3.26

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

13.86

Max

14.76

Belangrijke statistieken

By Trading Economics

Aanbevelingen

By TipRanks

Aanbevelingen

Sell

12 Maanden Prognose

-29.33% downside

Emeis SA Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

7 jan 2026, 23:11 UTC

Winsten

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7 jan 2026, 22:55 UTC

Belangrijke Marktbewegers

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7 jan 2026, 21:39 UTC

Belangrijke Marktbewegers

Raytheon Down Following Trump Post Criticizing Company

7 jan 2026, 20:13 UTC

Belangrijke Marktbewegers

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7 jan 2026, 20:03 UTC

Belangrijke Marktbewegers

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7 jan 2026, 23:46 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

7 jan 2026, 23:46 UTC

Marktinformatie

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7 jan 2026, 23:42 UTC

Acquisities, Fusies, Overnames

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7 jan 2026, 23:34 UTC

Marktinformatie

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7 jan 2026, 23:29 UTC

Acquisities, Fusies, Overnames

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7 jan 2026, 22:48 UTC

Marktinformatie

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7 jan 2026, 22:46 UTC

Winsten

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7 jan 2026, 22:45 UTC

Winsten

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7 jan 2026, 22:43 UTC

Acquisities, Fusies, Overnames

Revolution Medicines Draws Takeover Interest -- 2nd Update

7 jan 2026, 22:42 UTC

Winsten

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7 jan 2026, 22:41 UTC

Winsten

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7 jan 2026, 22:41 UTC

Winsten

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7 jan 2026, 22:40 UTC

Belangrijke Marktbewegers

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7 jan 2026, 22:31 UTC

Marktinformatie

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7 jan 2026, 22:22 UTC

Marktinformatie

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7 jan 2026, 22:01 UTC

Marktinformatie

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7 jan 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

7 jan 2026, 21:46 UTC

Marktinformatie

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7 jan 2026, 21:22 UTC

Acquisities, Fusies, Overnames

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7 jan 2026, 21:18 UTC

Acquisities, Fusies, Overnames

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7 jan 2026, 21:05 UTC

Acquisities, Fusies, Overnames

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7 jan 2026, 20:29 UTC

Acquisities, Fusies, Overnames

AbbVie Near Deal for Revolution Medicines -- Update

7 jan 2026, 20:27 UTC

Marktinformatie

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7 jan 2026, 19:58 UTC

Marktinformatie

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7 jan 2026, 19:48 UTC

Belangrijke Marktbewegers

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Emeis SA Prognose

Koersdoel

By TipRanks

-29.33% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 10 EUR  -29.33%

Hoogste 10 EUR

Laagste 10 EUR

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Emeis SA - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Sell

1 ratings

0

Buy

0

Hold

1

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Emeis SA

emeis Société anonyme operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logistical and residential services, including accommodation, meals, and laundry and room cleaning, as well as various daily event, entertainment, and therapeutic workshop services. The company's post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state. Its psychiatric hospitals provide services for the patients with mood disorders, anxiety disorders, obsessive-compulsive disorders, addictions, eating disorders, sleep disorders, personality disorders, ageing-related psychiatric disorders, psychosis, over exhaustion or burn-out, chronic fatigue syndrome, fibromyalgia, psychosomatic conditions, and post-traumatic stress disorder conditions, as well as geriatric, child, young adult, parent-child, and public/private patients psychiatry services. In addition, the company offers home care services, including housekeeping services, such as cleaning, meals, ironing, gardening, and household errands; daily life assistance services comprising day or night supervision, assistance with hygiene tasks, and meal-time assistance; and movement assistance services. It operates in France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China. The company was founded in 1989 and is headquartered in Puteaux, France.
help-icon Live chat